Syphilis is a sexually transmitted infection commonly associated with painless skin lesions of the genitalia. It is also known as the "great imitator" since it can manifest in a variety of other presentations, including in the eye.
This case highlights the importance of recognizing ocular manifestations of syphilis despite negative results for highly sensitive nontreponemal serological tests. The authors recommend that both nontreponemal and treponemal serology be evaluated in patients presenting with unexplained acute visual loss and ocular inflammation.
Although syphilis had been nearly eradicated from the United States in 2000, the Centers for Disease Control and Prevention (CDC) reports an accelerated increase in the rates of syphilis infection from 2005 to 2013. 1 Syphilis is a sexually transmitted infection caused by the spirochete bacterium Treponema pallidum. After initial infection of a host, T. pallidum is able to invade the bloodstream and disseminate from its primary site of infection. 2, 3 This unique biological property accounts for the myriad of systemic manifestations associated with syphilis, which could easily be misdiagnosed as another condition. With the increased incidence of syphilis in the United States, it is essential to raise physician awareness of syphilis' unusual presentations. This case report describes an ocular manifestation of syphilis and discusses the limitations of serological diagnostic tools.
INTRODUCTION
A 44-year-old male presented to the retina clinic after awaking with a gray spot in his left eye that increased in size as the day progressed. Four days prior, he was treated for left deep thigh infection with overlying cellulitis; he received a single dose of intravenous (IV) vancomycin 1000 mg and piperacillin/tazobactam 3.375 mg, and subsequently began a 9-day oral regimen of amoxicillin 875mg/clavulante 125mg. Also of note, he had previously been treated for secondary syphilis with intramuscular (IM) penicillin 18 years prior. If untreated, syphilis progresses through a series of four stages, with each demonstrating generalizable characteristics (Table 1) . After approximately 3 to 6 weeks of incubation, primary syphilis manifests as a painless chancre at the original site of inoculation. [2] [3] [4] Local immune responses are typically able to clear T. pallidum, healing the chancre within 3 to 8 weeks. 3 As a result, primary syphilis may often go undetected. But within hours of infection, T. pallidum has already invaded the bloodstream and spread systemically. 
SYPHILIS IN THE EYE BRIEF REPORTS
the symptoms of secondary syphilis do not appear until 3 to 6 months after initial inoculation. [2] [3] [4] When secondary syphilis does manifest itself, it may present with involvement of various organ systems depending on the seeding of T. pallidum. 2, 3 Again, the immune system is able to mount an inflammatory response against T. pallidum, resolving symptoms within 3 months of onset. 2 However, a subpopulation of T. pallidum develops resistance to phagocytosis and is able to persist in an asymptomatic latent stage. 2, 3, 5 This latent stage can be divided into early (less than 1 year after infection) and late (more than 1 year after infection), with 25% of early latent patients relapsing to secondary syphilis. 2, 3 Approximately one-third of patients with latent syphilis progress to tertiary syphilis. 2 Though a rare occurrence typically seen with secondary or tertiary syphilis, 2-4 ocular involvement has been reported in all structures of the eye. 6 Specifically, posterior uveitis has been reported to be the most common complication of ocular syphilis. [6] [7] [8] This posterior segment involvement is most often manifested as ASPPC. 8 Early cases reported by de Sousa et al. 9 and Gass et al. 10 described a large, yellowish placoid lesion in or near the macula at the level of the retinal pigment epithelium (RPE), with diffuse leakage apparent on FFA. A recent study by Pichi et al. 8 described the OCT findings characteristic of ASPPC: IS-OS junction disruption, nodular RPE thickening, and, in some cases, subretinal fluid accumulation, external limiting membrane loss, and choroidal punctate hyperreflectivity. Additionally, although early work 10 suggested that immunocompromised status was responsible for ASPPC, more recent findings 8, 11 have demonstrated the prevalence of ASPPC in immunocompetent patients as well. Because T. pallidum has limited metabolic capacity 2 and cannot be cultured, diagnosis of syphilis relies upon clinical presentation and serological analysis. Typically, highly sensitive nontreponemal tests (RPR and VDRL) are used as frontline screening measures, followed by highly specific treponemal tests (fluorescent treponemal antibody absorption [FTA-ABS]) only in cases of reactive nontreponemal tests. 4, 12, 13 However, studies have noted rather high falsenegative rates (roughly 30%) in nontreponemal tests. 8, 14 Tamesis and Foster 14 even went on to recommend that routine FTA-ABS tests be conducted in conjunction with nontreponemal screenings.
The standard treatment for syphilis is parenteral penicillin, with dosage and method of administration depending upon the stage of syphilis. Adequate alternative treatments in cases of penicillin allergy have been reported to include macrolides, cephalosporins, and tetracyclines. 3, 15 Amoxicillin has also been reported to possess antitreponemal activity equivalent to that of penicillin, though at noticeably higher concentrations (0.018mg/L penicillin vs. 0.42mg/L amoxicillin). 15 Additionally, vancomycin has been observed to demonstrate some, though not therapeutically effective, activity against T pallidum.
15
Although the presented patient had negative RPR and CSF VDRL tests, his clinical findings were most consistent with ASPPC and his symptoms resolved with antibiotic treatment. While it remains unclear if the patient experienced relapse of or reinfection with syphilis, his ocular manifestations of syphilis may have been precipitated by his immune system's inflammatory response to his groin infection. The subsequent rounds of antibiotics he received for his groin infection are likely to have incidentally treated his ASPPC. Although no known studies have explored the use of amoxicillin in the context of ASPPC, Morrison et al. 16 and O'Mahony et al. 17 have demonstrated amoxicillin's antitreponemal activity in the settings of neurosyphilis and late stage syphilis, respectively. This hypothesis is supported by the patient's early resolution of central serous detachment and subretinal fluid accumulation prior to initiation of IV penicillin G. Also of note, the presentation of ASPPC in his left eye is in accordance with the unexplained preponderance of left-sided uniocular ASPPC recently reported by Matthew et al. 18 Incidental treatment of syphilis by antibiotics prescribed for other infections has been hypothesized to explain the low incidences of tertiary syphilis observed. 2 This hypothesis may certainly explain the events described in this case report.
As the incidence of syphilis infection is on the rise, the usual manifestations of syphilis will become more pervasive in all fields of medicine. It is imperative to recognize these early symptoms of syphilis before infection progresses to its more debilitating forms. Therefore, the authors emphasize the importance of considering the possible diagnosis of syphilis in patients presenting with acute ocular inflammation. Additionally, the authors recommend that gold standard FTA-ABS tests be conducted in these patients, regardless of nontreponemal test reactivity.
1. Syphilis can manifest in a variety of presentations, including as acute ocular inflammation.
2. Both nontreponemal and treponemal tests should be conducted to accurately screen for syphilis.
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